NCT03716700View on ClinicalTrials.gov

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

CompletedOBSERVATIONAL

Enrollment

126

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

July 23, 2020

Study Completion Date

July 23, 2020

Conditions

Primary Immunodeficiency Diseases (PID)

Interventions

BIOLOGICAL

CUVITRU

Trial Locations (3)

L8S 4L8

University of McMaster, Hamilton

N2M 5E2

Grand River Allergy, Kitchener

M5G 1E2

Toronto Allergists, Toronto

All Listed Sponsors

collaborator

Baxalta Innovations GmbH, now part of Shire

INDUSTRY

lead

Baxalta now part of Shire

INDUSTRY

NCT03716700 - Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN) | Biotech Hunter | Biotech Hunter